Brown Brothers Harriman & CO Gsk PLC Transaction History

Brown Brothers Harriman & CO

$14 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$42.05 - $47.77 $1,387 - $1,576	33 Added 0.34%	9,778 $426,000
Q1 2022 May 13, 2022	BUY	$40.23 - $47.74 $136,178 - $161,599	3,385 Added 53.22%	9,745 $424,000
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $8,514 - $9,922	219 Added 3.57%	6,360 $280,000
Q2 2021 Aug 13, 2021	SELL	$36.52 - $41.46 $9,166 - $10,406	-251 Reduced 3.93%	6,141 $245,000
Q1 2021 May 13, 2021	SELL	$34.27 - $40.01 $72,858 - $85,061	-2,126 Reduced 24.96%	6,392 $228,000
Q4 2020 Feb 16, 2021	BUY	$34.07 - $39.94 $3,372 - $3,954	99 Added 1.18%	8,518 $313,000
Q3 2020 Nov 16, 2020	SELL	$38.11 - $42.99 $14,748 - $16,637	-387 Reduced 4.39%	8,419 $317,000
Q2 2020 Aug 13, 2020	BUY	$37.87 - $43.58 $85,510 - $98,403	2,258 Added 34.48%	8,806 $359,000
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $159,947 - $240,536	-4,926 Reduced 42.93%	6,548 $248,000
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $115,374 - $132,542	2,747 Added 31.48%	11,474 $539,000
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $206,265 - $221,864	-5,098 Reduced 36.88%	8,727 $372,000
Q2 2019 Aug 14, 2019	BUY	$39.4 - $42.7 $57,327 - $62,128	1,455 Added 11.76%	13,825 $553,000
Q1 2019 May 15, 2019	BUY	$38.57 - $42.69 $234,852 - $259,939	6,089 Added 96.94%	12,370 $517,000
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $15,119 - $17,076	-400 Reduced 5.99%	6,281 $240,000
Q3 2018 Nov 14, 2018	BUY	$39.75 - $42.69 $5,565 - $5,976	140 Added 2.14%	6,681 $268,000
Q2 2018 Aug 14, 2018	SELL	$39.61 - $42.76 $30,420 - $32,839	-768 Reduced 10.51%	6,541 $264,000
Q2 2017 Aug 14, 2017	BUY	N/A	7,309	7,309 $315,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account